We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
+16.59%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
AUM
$1.97B
AUM Growth
+$462M
Cap. Flow
+$300M
Cap. Flow %
15.22%
Top 10 Hldgs %
42.48%
Holding
381
New
48
Increased
134
Reduced
138
Closed
29

Top Sells

Rank Stock Value
1
ADSK icon
Autodesk
ADSK
+$13.6M
2
NOW icon
ServiceNow
NOW
+$13M
3
INTU icon
Intuit
INTU
+$11.6M
4
ABT icon
Abbott
ABT
+$8.28M
5
HON icon
Honeywell
HON
+$8.01M

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.32%
2 Technology 19.69%
3 Healthcare 11.97%
4 Industrials 8.31%
5 Consumer Discretionary 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
76
Ecolab
ECL
$78.3B
$5.1M 0.26%
18,314
-742
-4% -$195K
TJX icon
77
TJX Companies
TJX
$145B
$5.07M 0.26%
33,435
-751
-2% -$119K
EPD icon
78
Enterprise Products Partners
EPD
$84.1B
$4.88M 0.25%
132,631
-1,800
-1% -$67.9K
UTHR icon
79
United Therapeutics
UTHR
$20.9B
$4.86M 0.25%
8,975
+591
+7% +$333K
MS icon
80
Morgan Stanley
MS
$342B
$4.77M 0.24%
22,804
+3,602
+19% +$713K
LMT icon
81
Lockheed Martin
LMT
$121B
$4.64M 0.24%
9,107
-183
-2% -$98.9K
LRCX icon
82
Lam Research
LRCX
$385B
$4.55M 0.23%
10,494
+2,037
+24% +$618K
MANE
83
Veradermics Inc
MANE
$4.12B
$4.42M 0.22%
+35,967
New +$3.37M
WMT icon
84
Walmart Inc
WMT
$850B
$4.41M 0.22%
38,962
+2,532
+7% +$314K
TRVI icon
85
Trevi Therapeutics
TRVI
$2.46B
$4.37M 0.22%
234,208
+2,606
+1% +$37.9K
NKTR icon
86
Nektar Therapeutics
NKTR
$2.53B
$4.23M 0.21%
60,585
-519
-0.8% -$38K
SVRA icon
87
Savara
SVRA
$1.1B
$4.06M 0.21%
658,354
+7,330
+1% +$39.3K
IBM icon
88
IBM
IBM
$221B
$3.97M 0.2%
14,105
+3,736
+36% +$941K
VTWO icon
89
Vanguard Russell 2000 ETF
VTWO
$17B
$3.82M 0.19%
31,447
+76
+0.2% +$8.63K
HCA icon
90
HCA Healthcare
HCA
$87.7B
$3.78M 0.19%
9,701
-312
-3% -$132K
PNC icon
91
PNC Financial Services
PNC
$98B
$3.7M 0.19%
15,031
+1,280
+9% +$287K
NEE icon
92
NextEra Energy
NEE
$174B
$3.66M 0.19%
41,649
-823
-2% -$74.4K
DNTH icon
93
Dianthus Therapeutics
DNTH
$6.05B
$3.5M 0.18%
+35,875
New +$3.13M
TMDX icon
94
Transmedics
TMDX
$3.12B
$3.45M 0.18%
51,906
+11,820
+29% +$1M
TSLA icon
95
Tesla
TSLA
$1.4T
$3.37M 0.17%
8,017
+2,014
+34% +$801K
UNH icon
96
UnitedHealth
UNH
$356B
$3.34M 0.17%
8,043
+897
+13% +$332K
AXSM icon
97
Axsome Therapeutics
AXSM
$10.8B
$3.28M 0.17%
13,409
+141
+1% +$30.6K
BLK icon
98
Blackrock
BLK
$174B
$3.18M 0.16%
3,307
-74
-2% -$76.5K
BSJT icon
99
Invesco BulletShares 2029 High Yield Corporate Bond ETF
BSJT
$596M
$3.1M 0.16%
+146,475
New +$3.11M
QQQ icon
100
Invesco QQQ Trust
QQQ
$489B
$3.05M 0.16%
4,146
+384
+10% +$264K

Similar funds

F/M Investments's Q2 2026 Portfolio in Review

As of Q2 2026, F/M Investments held 381 positions worth $1.97B, up 31% from $1.51B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

F/M Investments deployed $300M of net new capital in Q2 2026, opening 48 new positions and adding to 134 existing holdings. Its largest new stake was Invesco Short Term Treasury ETF: 1,034,448 shares worth $109M.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, up from 28% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was ServiceNow, an estimated $13M trimmed.

  • F/M Investments's largest Q2 2026 buy was Invesco Short Term Treasury ETF: 1,034,448 shares worth $109M.
  • F/M Investments added most to iShares Core US Aggregate Bond ETF in Q2 2026, an estimated $144M increase.
  • F/M Investments's biggest Q2 2026 reduction was ServiceNow, cutting an estimated $13M.
  • F/M Investments fully exited Autodesk in Q2 2026, selling an estimated $13.6M.
  • F/M Investments's ten largest holdings make up 42% of its $1.97B portfolio in Q2 2026.
  • F/M Investments opened 48 new positions and closed 29 in Q2 2026.
  • F/M Investments's portfolio value rose 31% quarter-over-quarter to $1.97B.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.